Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Summary

RATIONALE: Losartan potassium may be effective in treating pulmonary fibrosis caused by radiation therapy in patients with non-small cell lung cancer. PURPOSE: This clinical trial is studying losartan to see how well it works in treating pulmonary fibrosis caused by radiation therapy in patients with stage I, stage II, or stage III non-small cell lung cancer.

Timeline

Start

2009-03

Primary completion

2010-04

Completion

2010-04

Outcome

Outcome not reported

Stopped (Enrollment): “Study concept was not approved by NCI. Study was never activated. No enrollment”

Drugs

Indications